Non-invasive sampling methods of inflammatory biomarkers in asthma and allergic rhinitis
Boot, J.D.
Citation
Boot, J. D. (2009, September 10). Non-invasive sampling methods of inflammatory biomarkers in asthma and allergic rhinitis. Retrieved from https://hdl.handle.net/1887/13967
Version: Corrected Publisher’s Version License:
Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden
Downloaded from: https://hdl.handle.net/1887/13967
Note: To cite this publication please use the final published version (if
applicable).
191 bibliogr aphy
bibliogr aphy
1 Belkowski SM, Boot JD, Mascelli MA, Diamant Z, de Garavilla L, Hertzog B, Polkovitch D, Towers M, Batheja A, D’Andrea MR. Cleaved secretory leucocyte protease inhibitor as a biomarker of chymase activity in allergic airway disease. Clin Exp Allergy. 2009; 39:
1179-1186
2 Wang WY, Boot JD, Mascelli MA, Gerth van Wijk R, Diamant Z. Comparison of biomarkers between allergic rhinitis only and allergic rhinitis with concomitant asthma. Allergy. 2009 Feb 16. [Epub ahead of print]
3 Boot JD, Chandoesing P, de Kam ML, Mascelli MA, Das AM, Gerth van Wijk R, de Groot H, Verhoosel R, Hiemstra PS, Diamant Z. Applicability and reproducibility of biomarkers for the evaluation of anti-inflammatory therapy in allergic rhinitis. J Investig Allergol Clin Immunol. 2008;18(6):433-42.
4 Boot JD, de Ridder L, de Kam ML, Calderon C, Mascelli MA, Diamant Z. Comparison of exhaled nitric oxide measurements between niox mino electrochemical and Ecomedics chemiluminescence analyzer. Respir Med. 2008;102(11):1667-71.
5 Diamant Z, Boot D, Kamerling I, Bjermer L. Methods used in clinical development of novel anti-asthma therapies. Respir Med. 2008;102(3):332-8.
6 Boot JD, De Haas SL, Van Gerven JM, De Smet M, Leathem T, Wagner J, Denker A, Miller D, Van Doorn MB, Schoemaker RC, Cohen AF, Diamant Z.
MK-0873, a PDE4 inhibitor, does not influence the pharmacokinetics of theophylline in healthy male volunteers. Pulm Pharmacol Ther. 2008;21(3):573-7.
7 Boot JD, de Kam ML, Mascelli MA, Miller B, van Wijk RG, de Groot H, Cohen AF, Diamant Z. Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis. Allergy. 2007;62(4):378-84.
8 Diamant Z, Boot JD, Virchow JC. Summing up 100 years of asthma. Respir Med. 2007;101(3):378-88.
9 Boot JD, de Haas S, Tarasevych S, Roy C, Wang L, Amin D, Cohen J, Sterk PJ, Miller B, Paccaly A, Burggraaf J, Cohen AF, Diamant Z. Effect of an nk1/
nk2 receptor antagonist on airway responses and inflammation to allergen in asthma. Am J Respir Crit Care Med. 2007;175(5):450-7.
10 Boot JD, Panzner P, Diamant Z. A critical appraisal of methods used in early clinical development of novel drugs for the treatment of asthma. Pulm Pharmacol Ther. 2007;20(3):201-19.
11 Diamant Z, Boot JD, Tarasevych S, Fokkens WJ, de Groot H, Gerth van Wijk R. [‘Verenigde luchtwegen: implicaties voor diagnostiek en behandeling van het çombined allergic rhinitis and asthma syndrome’] Dutch. Ned Tijdschr Allergie, 2006;6:84-91.
12 Boot JD, Tarasevych S, Sterk PJ, Schoemaker RC, Wang L, Amin D, Cohen AF, Diamant Z. Reversal of the late asthmatic response increases exhaled nitric oxide. Respir Med. 2005;99(12):1591-4.
192 non - invasive sampling methods of infl ammatory biomarkers in asthma and allergic rhinitis